Fendrix er indiceret til aktiv immunisering mod hepatitis B- infektion (HBV), forårsaget af alle kendte subtyper hos patienter med nyreinsufficiens (herunder præ- hæmodialyse og hæmodialyse patienter) på 15 år og derover.
Fendrix is indicated for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes for patients with renal insufficiency (including pre-haemodialysis and haemodialysis patients), from the age of 15 years onwards.